These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 10581072)

  • 21. Parkinson syndrome. Heterogeneity of etiology; heterogeneity of pathogenesis?
    Albin RL; Dauer WT
    Neurology; 2012 Jul; 79(3):202-3. PubMed ID: 22722622
    [No Abstract]   [Full Text] [Related]  

  • 22. Role of inflammatory factors in neurodegeneration.
    Członkowska A; Kurkowska-Jastrzebska I; Członkowski A
    Neurol Neurochir Pol; 2001; 35 Suppl 3():13-22. PubMed ID: 12001649
    [No Abstract]   [Full Text] [Related]  

  • 23. Nitric-oxide synthase and neurodegeneration/neuroprotection.
    Kaufman PL
    Proc Natl Acad Sci U S A; 1999 Aug; 96(17):9455-6. PubMed ID: 10449712
    [No Abstract]   [Full Text] [Related]  

  • 24. Inducible nitric oxide synthase: what difference does it make?
    Nathan C
    J Clin Invest; 1997 Nov; 100(10):2417-23. PubMed ID: 9366554
    [No Abstract]   [Full Text] [Related]  

  • 25. Nitric oxide in neuronal degeneration.
    Dawson VL; Dawson TM
    Proc Soc Exp Biol Med; 1996 Jan; 211(1):33-40. PubMed ID: 8594616
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Difference gel electrophoresis.
    Unlü M
    Biochem Soc Trans; 1999 Aug; 27(4):547-9. PubMed ID: 10917639
    [No Abstract]   [Full Text] [Related]  

  • 27. Quicker, easier, and cheaper? The promise of automated hand hygiene monitoring.
    Stewardson A; Pittet D
    Infect Control Hosp Epidemiol; 2011 Oct; 32(10):1029-31. PubMed ID: 21931254
    [No Abstract]   [Full Text] [Related]  

  • 28. Modulation of peroxynitrite produced via mitochondrial nitric oxide synthesis during Ca
    Gerdes HJ; Yang M; Heisner JS; Camara AKS; Stowe DF
    Biochim Biophys Acta Bioenerg; 2020 Dec; 1861(12):148290. PubMed ID: 32828729
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Effects of Calorie Restriction and Exercise on Age-Related Alterations in Corpus Cavernosum.
    Macit C; Ustundag UV; Dagdeviren OC; Mercanoglu G; Sener G
    Front Physiol; 2020; 11():45. PubMed ID: 32132927
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aging related erectile dysfunction-potential mechanism to halt or delay its onset.
    Ferrini MG; Gonzalez-Cadavid NF; Rajfer J
    Transl Androl Urol; 2017 Feb; 6(1):20-27. PubMed ID: 28217447
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevention of the degeneration of human dopaminergic neurons in an astrocyte co-culture system allowing endogenous drug metabolism.
    Efremova L; Schildknecht S; Adam M; Pape R; Gutbier S; Hanf B; Bürkle A; Leist M
    Br J Pharmacol; 2015 Aug; 172(16):4119-32. PubMed ID: 25989025
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Growth hormone releasing hormone induces the expression of nitric oxide synthase.
    Barabutis N; Siejka A; Schally AV
    J Cell Mol Med; 2011 May; 15(5):1148-55. PubMed ID: 20518847
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure-based design and synthesis of N(omega)-nitro-L-arginine-containing peptidomimetics as selective inhibitors of neuronal nitric oxide synthase. Displacement of the heme structural water.
    Seo J; Igarashi J; Li H; Martasek P; Roman LJ; Poulos TL; Silverman RB
    J Med Chem; 2007 May; 50(9):2089-99. PubMed ID: 17425297
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microarray analysis of oxidative stress regulated genes in mesencephalic dopaminergic neuronal cells: relevance to oxidative damage in Parkinson's disease.
    Anantharam V; Lehrmann E; Kanthasamy A; Yang Y; Banerjee P; Becker KG; Freed WJ; Kanthasamy AG
    Neurochem Int; 2007 May; 50(6):834-47. PubMed ID: 17397968
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NOS knockouts and neuroprotection.
    Grünewald T; Beal MF
    Nat Med; 1999 Dec; 5(12):1354-5. PubMed ID: 10581072
    [No Abstract]   [Full Text] [Related]  

  • 36. Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease.
    Liberatore GT; Jackson-Lewis V; Vukosavic S; Mandir AS; Vila M; McAuliffe WG; Dawson VL; Dawson TM; Przedborski S
    Nat Med; 1999 Dec; 5(12):1403-9. PubMed ID: 10581083
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation by NO of acetylcholine release in the ileum of wild-type and NOS gene knockout mice.
    Mang CF; Truempler S; Erbelding D; Kilbinger H
    Am J Physiol Gastrointest Liver Physiol; 2002 Nov; 283(5):G1132-8. PubMed ID: 12381527
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nitric oxide synthase 1 is partly compensating for nitric oxide synthase 3 deficiency in nitric oxide synthase 3 knock-out mice and is elevated in murine and human cirrhosis.
    Biecker E; Neef M; Sägesser H; Shaw S; Koshy A; Reichen J
    Liver Int; 2004 Aug; 24(4):345-53. PubMed ID: 15287858
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nitric oxide in the pathogenesis of Parkinson's disease.
    Gerlach M; Blum-Degen D; Lan J; Riederer P
    Adv Neurol; 1999; 80():239-45. PubMed ID: 10410728
    [No Abstract]   [Full Text] [Related]  

  • 40. Mouse models of nitric oxide synthase deficiency.
    Huang PL
    J Am Soc Nephrol; 2000 Nov; 11 Suppl 16():S120-3. PubMed ID: 11065342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.